Skip Navigation


Rheumatology Advance Access originally published online on August 18, 2008
Rheumatology 2008 47(10):1571-1576; doi:10.1093/rheumatology/ken323
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
47/10/1571    most recent
ken323v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by van Tuyl, L. H. D.
Right arrow Articles by Boers, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Tuyl, L. H. D.
Right arrow Articles by Boers, M.
Related Collections
Right arrow Pharmacology
Right arrow Rheumatoid Arthritis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis

L. H. D. van Tuyl1, A. M. C. Plass2, W. F. Lems3, A. E. Voskuyl3, P. J. S. M. Kerstens4, B. A. C. Dijkmans3 and M. Boers1

1Department of Clinical Epidemiology and Biostatistics, 2EMGO-Institute, 3Department of Rheumatology, VU University Medical Center and 4Jan van Breemen Institute, Amsterdam, The Netherlands.

Correspondence to: L. H. D. van Tuyl, Department of Clinical Epidemiology and Biostatistics, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail: L.vantuyl{at}vumc.nl


   Abstract

Objective. The COBRA therapy (combination therapy in early rheumatoid arthritis) has proven to be an effective treatment for early RA, but is rarely prescribed. A survey showed reluctance of Dutch reumatologists to apply COBRA therapy in early RA. The present qualitative study was carried out to further explore the reservation of Dutch rheumatologists towards prescribing COBRA therapy and include patients’ view on (components of) COBRA therapy.

Methods. Two focus group discussions were undertaken for rheumatologists (n1 = 8, n2 = 7) and two for patients (n1 = 4, n2 = 8). In addition, in-depth interviews were conducted with 11 rheumatologists and 1 patient. These were taped and transcribed. Two independent researchers identified themes and these were discussed with three other researchers.

Results. Rheumatologists were positive concerning effectiveness of COBRA therapy, but highly concerned about their patients’ possible negative reaction to the large amount of pills to be prescribed. In addition, rheumatologists perceived lack of time explaining and prescribing COBRA therapy and felt uncomfortable prescribing high doses of prednisolone. Patients were positive about an aggressive combination therapy such as COBRA, and they had no qualms taking many pills if this could improve their prognosis. Patients associated prednisolone with negative side-effects, but were also aware of the benefits and the need of prednisolone in rough times. A decrease in the amount of pills after intensive treatment was highly appreciated.

Conclusion. Rheumatologists and patients differed in opinion about the use of COBRA therapy. Rheumatologists were particularly concerned about their patients’ reaction towards them prescribing such an aggressive and complex therapy, whereas patients, while aware of the side-effects, were most interested in suppressing illness symptoms and reducing future damage regardless of the amount of pills.

KEY WORDS: Rheumatoid arthritis, Combination therapy, Qualitative, Focus group, Patient perspective, COBRA therapy, Glucocorticoids

Submitted 7 February 2008; revised version accepted 9 July 2008.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
L. H.D. van TUYL, A. M. C. PLASS, W. F. LEMS, A. E. VOSKUYL, P. J.S.M. KERSTENS, B. A.C. DIJKMANS, and M. BOERS
Facilitating the Use of COBRA Combination Therapy in Early Rheumatoid Arthritis: A Pilot Implementation Study
J Rheumatol, July 1, 2009; 36(7): 1380 - 1386.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.